When my blood sugar crashes, it goes down below 4%
Here's a simple example our team might suggest, your plan is always personalized to you
As AFib continues to affect more patients worldwide, clinicians need new strategies to reduce risk and improve long-term outcomes, presenting author Kenneth Bilchick, MD, professor of cardiovascular medicine at the University of Virginia, explained in a statement These findings suggest GLP-1-RAs may influence heart rhythm through mechanisms beyond weight loss
On March 3, 2026, the FDA announced it had issued 30 warning letters to telehealth companies regarding allegedly false or misleading compounded GLP-1 marketing claims
Removing DAC restored natural pulse dynamics
Novo Nordisk only launched oral Wegovy in January, and is banking on the new formulation making strong sales as it faces pressure on its injectable version of semaglutide for weight loss